Indicated for adult patients with: 🔹 Progressive Medullary Thyroid Cancer (MTC): Typically used as part of the starting dose regimen (140 mg daily). 🔹 Advanced Renal Cell Carcinoma (RCC) / Hepatocellular Carcinoma (HCC): Depending on oncologist prescription and dose modifications.

Dosage and administration

Packaging: 80 mg capsules. ⚠️ ADMINISTRATION PROTOCOL: Dosage: As prescribed. Often taken once daily. Food Intake: ⛔ Must be taken on an empty stomach. No food for at least 2 hours before and 1 hour after administration. Administration: Swallow whole with a full glass of water. Do not open or crush. Warning: Avoid grapefruit products as they increase blood levels of the drug.

Hypersensitivity to Cabozantinib. Recent history of severe hemorrhage or GI perforation. Severe hepatic impairment. Pregnancy and breastfeeding.

Common adverse reactions include: 🩸 Cardiovascular: Hypertension, venous thromboembolism. 📉 Gastrointestinal: Diarrhea (frequent), nausea, mucositis, abdominal pain. 🖐 Dermatologic: Hand-foot skin reaction (PPES), hair color changes. 🌀 Systemic: Fatigue, weight loss, decreased appetite.

Caboxen 80 — Cabozantinib 80 mg, 30 pcs, Everest

100% original product

Active ingredient

Cabozantinib

Manufacturer

Everest

Dosage 80 mg

Dosage form Capsules

Capsules per pack 30

Caboxen 80 (Cabozantinib) 80 mg Capsules

Name: Caboxen 80
Brand: Everest
SKU: PROD-148
Price: 25930 UAH
Availability: InStock

25930₴ ~~27688₴~~ -6%

Caboxen 80 mg (Cabozantinib) is a high-strength tyrosine kinase inhibitor targeting VEGFR, MET, and AXL pathways used in advanced oncology.

Manufacturer: Everest Pharmaceuticals. Each pack contains 30 capsules. This 80 mg strength is primarily utilized in treatment regimens requiring higher daily dosages, such as for medullary thyroid cancer, effectively cutting off the tumor's blood supply.

Key Feature:

Designed to overcome tumor resistance. The 80 mg capsule is a key component of the 140 mg daily protocol (often combined with 20 mg capsules) for specific thyroid cancers.

Indicated for adult patients with:

🔹 Progressive Medullary Thyroid Cancer (MTC): Typically used as part of the starting dose regimen (140 mg daily).
🔹 Advanced Renal Cell Carcinoma (RCC) / Hepatocellular Carcinoma (HCC): Depending on oncologist prescription and dose modifications.

Packaging: 80 mg capsules.

⚠️ ADMINISTRATION PROTOCOL:

Dosage: As prescribed. Often taken once daily.
Food Intake: ⛔ Must be taken on an empty stomach. No food for at least 2 hours before and 1 hour after administration.
Administration: Swallow whole with a full glass of water. Do not open or crush.
Warning: Avoid grapefruit products as they increase blood levels of the drug.

Hypersensitivity to Cabozantinib.
Recent history of severe hemorrhage or GI perforation.
Severe hepatic impairment.
Pregnancy and breastfeeding.

Common adverse reactions include:

🩸 Cardiovascular: Hypertension, venous thromboembolism.
📉 Gastrointestinal: Diarrhea (frequent), nausea, mucositis, abdominal pain.
🖐 Dermatologic: Hand-foot skin reaction (PPES), hair color changes.
🌀 Systemic: Fatigue, weight loss, decreased appetite.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 18.03.2026

Active ingredient

Cabozantinib

Manufacturer

Everest

Dosage 80 mg

Dosage form Capsules

Capsules per pack 30

100% original product

Delivery across Ukraine

Alternatives

What Customers Say

No reviews yet

Your review can be the first!

Caboxen 80 (Cabozantinib) 80 mg Capsules

Similar products

Cazanat

Caboxen 20

What Customers Say

No reviews yet

Contact us

Request a call